Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The high prevalence of dermatophytosis in animals is usually associated with extra expenditure on prevention, diagnosis, and long‐term treatment. Humans are usually infected from animals, also from asymptomatic carriers, through direct contact or indirectly via fungus‐bearing hair, scales, and fomites. Despite the medical importance of <i>Trichophyton verrucosum</i> infections, there are limited <i>in vitro</i> data on the fungal susceptibility to antifungal drugs, including new‐generation triazoles, imidazoles, and allyloamines. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>The aim of the current study was to evaluate comprehensively the <i>in vitro</i> activity of 11 antifungal drugs against a large collection of <i>T. verrucosum</i> isolates obtained in Poland, Latvia, Lithuania, and Slovakia from humans and animals using a microdilution assay. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p><i>In vitro</i> susceptibility testing of 11 antifungal drugs was performed according to the Clinical and Laboratory Standards Institute (CLSI) document M38. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The MICs of clotrimazole, ciclopirox, enilconazole, miconazole, naftifine, and terbinafine against all <i>T. verrucosum</i> isolates were below 1 μg/ml, whereas those of fluconazole, griseofulvin, itraconazole, ketoconazole, and voriconazole were above 1 μg/ml. Ciclopirox was demonstrated to have superior activity against all strains in comparison with the other drugs, whereas fluconazole exerted the weakest <i>in vitro</i> effect and exhibited the highest MIC values. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our study has shown that drugs of different chemical origin have satisfactory antifungal activity and can be promising candidates for the treatment of <i>T. verrucosum</i> dermatophytosis. Moreover, no significant disparity in drug sensitivity between isolates obtained from different hosts and geographical regions have been demonstrated. </p></section>

In Vitro Activities of Nine Antifungal Drugs and Their Combinations against Phialophora verrucosa

In Vitro Interactions of Micafungin with Amphotericin B, Itraconazole or Fluconazole Against the Pathogenic Phase of Penicillium Marneffei.

In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii

In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales

In vitro activities of nine antifungal agents against rare pathogenic fungi.

In vitro activities of six antifungal agents and their combinations against Chaetomium spp.

In Vitro Testing of Amorolfine in Combination with Terbinafine and Itraconazone Against Fungal Isolates in Onychomycosis

In Vitro Activities of a Wide Panel of Antifungal Drugs against Various Scopulariopsis and Microascus Species

In Vitro Activities of Five Antifungal Agents Against Pathogenic Exophiala Species

In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs

Antifungal Activity of Antifungal Drugs, as Well as Drug Combinations Against Exophiala dermatitidis

In vitro susceptibility testing of the combination of terbinafine and itraconazole against dematiaceous fungi

Drug combinations against Mucor irregularis in vitro.

In Vitro Combined Activity of Amphotericin B, Caspofungin and Voriconazole Against Clinical Isolates of Trichosporon Asahii

In vitro activity of terbinafine in combinations with other antifungi drugs against clinical pathogenic fungi of vulvovaginal candidiasis

Antifungal activity of combination of caspofungin and voriconazole, itraconazole or amphotericin B against clinical strains of Scedosporium apiospermum in vitro

In Vitro Interaction of Terbinafine with Itraconazole and Amphotericin B Against Fungi Causing Chromoblastomycosis in China.

In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species

In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes

Comparison of in vitro activities of 11 antifungal agents against Trichophyton verrucosum isolates associated with a variety hosts and geographical origin

Antifungal susceptibility test for pathogenic Fusarium spp in vitro